Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C (Q61932996)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C |
clinical trial |
Statements
A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys®), With and Without Ribavirin (Copegus®) in Subjects With Hepatitis C (English)
0 references
August 2006
0 references
May 2008
0 references
334
0 references
18 year
0 references
65 year
0 references